These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33116357)

  • 1. Physiochemical Properties and Cytotoxicity of a Benzalkonium Chloride-Free, Micellar Emulsion Ophthalmic Formulation of Latanoprost.
    Halder A; Khopade AJ
    Clin Ophthalmol; 2020; 14():3057-3064. PubMed ID: 33116357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro toxicology study of travoprost polyquad-preserved, travoprost BAK-preserved, and latanoprost BAK-preserved ophthalmic solutions on human conjunctival epithelial cells.
    Brignole-Baudouin F; Riancho L; Liang H; Baudouin C
    Curr Eye Res; 2011 Nov; 36(11):979-88. PubMed ID: 21999224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma.
    Walimbe T; Chelerkar V; Bhagat P; Joshi A; Raut A
    Clin Ophthalmol; 2016; 10():821-7. PubMed ID: 27274186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination.
    Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Pharmacology of Latanoprost 0.005% without Benzalkonium Chloride Vs Latanoprost 0.005% with Benzalkonium Chloride in New Zealand White Rabbits and Beagles.
    Halder A; Khopade AJ
    Curr Eye Res; 2021 Jul; 46(7):1031-1037. PubMed ID: 33719796
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of In Vitro Corneal Permeation and In Vivo Ocular Bioavailability in Rabbits of Three Marketed Latanoprost Formulations.
    Chauchat L; Guerin C; Kaluzhny Y; Renard JP
    Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):633-645. PubMed ID: 37682463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel ophthalmic latanoprost 0.005% nanoemulsion: a cytotoxicity study.
    Tau J; Passerini MS; Del Papa M; Aguilar A; Berra A
    Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1941-1946. PubMed ID: 35015115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost.
    Katz G; Springs CL; Craven ER; Montecchi-Palmer M
    Clin Ophthalmol; 2010 Nov; 4():1253-61. PubMed ID: 21151330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of surfactants suitable for stabilizing of latanoprost.
    Ochiai A; Ohkuma M; Danjo K
    Int J Pharm; 2012 Oct; 436(1-2):732-7. PubMed ID: 22842310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro studies of antiglaucomatous prostaglandin analogues: travoprost with and without benzalkonium chloride and preserved latanoprost.
    Baudouin C; Riancho L; Warnet JM; Brignole F
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4123-8. PubMed ID: 17724196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzalkonium Chloride-Induced Corneal Epithelial Injury in Rabbit Reduced by Rebamipide.
    Fukuda M; Takeda N; Ishida H; Seki Y; Shibata N; Takahashi N; Sugiyama K; Kubo E; Sasaki H
    J Ocul Pharmacol Ther; 2022; 38(1):85-91. PubMed ID: 34936495
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of benzalkonium chloride-free travoprost in glaucoma patients switched from benzalkonium chloride-preserved latanoprost or bimatoprost.
    García-Feijoo J; Muñoz-Negrete FJ; Hubatsch DA; Rossi GC
    Clin Ophthalmol; 2016; 10():2085-2091. PubMed ID: 27799736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of benzalkonium chloride- or polyquad-preserved fixed combination glaucoma medications on human trabecular meshwork cells.
    Ammar DA; Kahook MY
    Mol Vis; 2011; 17():1806-13. PubMed ID: 21750606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.
    Aihara M; Otani S; Kozaki J; Unoki K; Takeuchi M; Minami K; Miyata K
    J Glaucoma; 2012 Jan; 21(1):60-4. PubMed ID: 21278589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension.
    Aptel F; Choudhry R; Stalmans I
    Curr Med Res Opin; 2016 Aug; 32(8):1457-63. PubMed ID: 27310103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the relative toxicity of travoprost 0.004% without benzalkonium chloride and latanoprost 0.005% in an immortalized human cornea epithelial cell culture system.
    Yee RW; Norcom EG; Zhao XC
    Adv Ther; 2006; 23(4):511-9. PubMed ID: 17050493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients.
    Kestelyn PA; Kestelyn PG; De Bacquer D; Stevens AM
    Int Ophthalmol; 2019 Jan; 39(1):105-109. PubMed ID: 29274019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models.
    Daull P; Buggage R; Lambert G; Faure MO; Serle J; Wang RF; Garrigue JS
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):515-23. PubMed ID: 22671995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ocular Surface Disease in Glaucoma Patients Randomized to Benzalkonium Chloride-Containing Latanoprost and Preservative-Free Bimatoprost.
    Wu JH; Wang TH; Huang JY; Su CC
    J Ocul Pharmacol Ther; 2021 Dec; 37(10):556-564. PubMed ID: 34610257
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.